Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-Surgical ADT With or Without Axitinib in Prostate Cancer
NCT01409200Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Mar 2012
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of axitinib in prostate cancer (PCa), sponsored by University of Texas MD Anderson Cancer Center. Started Mar 2012; status: completed.
02
Drugs
axitinib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01409200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01409200.